Glucose monitoring and insulin pump therapy in the management of children and adolescents with type 1 diabetes

Abstract

The artificial pancreas (closed-loop systems) automates insulin delivery at low and high glucose levels and is the centre of the current research. We outline results of recent outpatient studies, limitations and conditions for a widespread use. We conclude that transformational progress has been made in the last decade promising iterative improvements in diabetes outcomes and quality of life through technological innovations of the artificial pancreas and its components.